×

PetMed Express D/B/A 1-800-PetMeds Announces Its Third Quarter Financial Results and Its $0.19 Per Share Quarterly Dividend

Third Quarter New Order Sales Increased 4.4%

Third Quarter Sales Increased 3.8%

DELRAY BEACH, Fla., Jan. 23, 2017 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) today announced its financial results for the quarter ended December 31, 2016. Net sales for the quarter ended December 31, 2016 were $52.9 million, compared to $50.9 million for the quarter ended December 31, 2015, an increase of 3.8%. Net sales for the nine months ended December 31, 2016 were $186.1 million, compared to $179.3 million for the nine months ended December 31, 2015, an increase of 3.8%. The increase in sales for the quarter ended December 31, 2016 can be attributed to increased new order sales, which increased 4.4%, and reorder sales, which increased 3.7%. Net income for the quarter ended December 31, 2016 was $4.8 million, or $0.24 diluted per share, compared to net income of $4.9 million, or $0.24 diluted per share, for the quarter ended December 31, 2015, a 1.4% decrease to net income. Net income for the nine months ended December 31, 2016 was $16.3 million, or $0.80 diluted per share, compared to net income of $15.1 million, or $0.75 diluted per share, for the nine months ended December 31, 2015, a 7.7% increase to net income. Online sales for the quarter ended December 31, 2016 increased 5.6% to $43.8 million from $41.5 million for the same period the prior year. The Company’s online sales for the quarter ended December 31, 2016 were approximately 83% of all sales, compared to 81% for the same quarter the prior year.

Menderes Akdag, CEO and President, commented: “We are pleased to announce that the Company has officially moved to Delray Beach, having completed this transition in December 2016. Despite the transition, we continued to see sales growth in the December quarter where we saw increases in both new order and reorder sales. Our average order size increased to $81 for the quarter ended December 31, 2016, compared to $78 for the same quarter in the prior year. We were also encouraged with our advertising efficiency, as our new customer acquisition costs were reduced to $32 for the quarter ended December 31, 2016 compared to $41 for the same quarter in the prior year. Cash flow from operations was $31.6 million for the nine months ended December 31, 2016, compared to $22.6 million for the nine months ended December 31, 2015, with the majority of the increase due to a reduction in inventory.”

The Board of Directors declared a quarterly dividend of $0.19 per share on the Company’s common stock. The dividend will be payable on February 17, 2017, to shareholders of record at the close of business on February 6, 2017. The Company intends to continue to pay regular quarterly dividends; however, the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter’s financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on January 23, 2017 until February 6, 2017 at 11:59 P.M. To access the replay, call (888) 568-0521 (toll free) or (402) 998-1495 and enter passcode 5500.

Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2016. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 561-526-4444.

PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except for per share data)
December 31, March 31,
2016 2016
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$47,904 $37,639
Accounts receivable, less allowance for doubtful
accounts of $12 and $13, respectively 1,544 1,724
Inventories - finished goods 14,925 25,586
Prepaid expenses and other current assets 2,441 2,435
Prepaid income taxes 875 243
Total current assets 67,689 67,627
Noncurrent assets:
Property and equipment, net 29,071 20,929
Intangible assets 860 860
Deferred tax assets - 863
Total noncurrent assets 29,931 22,652
Total assets$97,620 $90,279
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable$5,391 $5,004
Accrued expenses and other current liabilities 2,543 2,080
Total current liabilities 7,934 7,084
Deferred tax liabilities 301 -
Total liabilities 8,235 7,084
Commitments and contingencies
Shareholders' equity:
Preferred stock, $.001 par value, 5,000 shares authorized;
3 convertible shares issued and outstanding with a
liquidation preference of $4 per share 9 9
Common stock, $.001 par value, 40,000 shares authorized;
20,527 and 20,447 shares issued and outstanding, respectively 21 20
Additional paid-in capital 6,430 4,871
Retained earnings 82,925 78,295
Total shareholders' equity 89,385 83,195
Total liabilities and shareholders' equity$97,620 $90,279


PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands, except for per share amounts) (Unaudited)
Three Months Ended Nine Months Ended
December 31, December 31,
2016 2015 2016 2015
Sales$52,866 $50,933 $186,144 $179,292
Cost of sales 36,223 34,179 128,985 120,659
Gross profit 16,643 16,754 57,159 58,633
Operating expenses:
General and administrative 5,361 4,977 17,206 16,164
Advertising 3,170 3,988 13,312 18,122
Depreciation 457 167 855 544
Total operating expenses 8,988 9,132 31,373 34,830
Income from operations 7,655 7,622 25,786 23,803
Other income:
Interest income, net 36 55 96 160
Other, net 130 (4) 206 (12)
Total other income 166 51 302 148
Income before provision for income taxes 7,821 7,673 26,088 23,951
Provision for income taxes 2,998 2,783 9,772 8,802
Net income$4,823 $4,890 $16,316 $15,149
Net change in unrealized loss on short
term investments - (14) - (33)
Comprehensive income$4,823 $4,876 $16,316 $15,116
Net income per common share:
Basic$0.24 $0.24 $0.81 $0.75
Diluted$0.24 $0.24 $0.80 $0.75
Weighted average number of common shares outstanding:
Basic 20,253 20,145 20,223 20,115
Diluted 20,408 20,251 20,373 20,232
Cash dividends declared per common share$0.19 $0.18 $0.57 $0.54


PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands) (Unaudited)
Nine Months Ended
December 31,
2016 2015
Cash flows from operating activities:
Net income $16,316 $15,149
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation 855 544
Share based compensation 1,444 1,189
Deferred income taxes 1,164 (109)
Bad debt expense 368 243
(Increase) decrease in operating assets
and increase (decrease) in liabilities:
Accounts receivable (188) 323
Inventories - finished goods 10,661 6,207
Prepaid income taxes (632) (334)
Prepaid expenses and other current assets 857 (895)
Accounts payable 387 212
Income taxes payable - (50)
Accrued expenses and other current liabilities 410 156
Net cash provided by operating activities 31,642 22,635
Cash flows from investing activities:
Net change in investments - (50)
Purchases of property and equipment (9,860) (177)
Net cash used in investing activities (9,860) (227)
Cash flows from financing activities:
Dividends paid (11,632) (10,984)
Tax adjustment related to restricted stock 115 92
Net cash used in financing activities (11,517) (10,892)
Net increase in cash and cash equivalents 10,265 11,516
Cash and cash equivalents, at beginning of period 37,639 35,613
Cash and cash equivalents, at end of period $47,904 $47,129
Supplemental disclosure of cash flow information:
Cash paid for income taxes $9,246 $9,203
Prepaid property and equipment in current assets $863 $-
Dividends payable in accrued expenses $196 $185

Source:PetMed Express, Inc.